|1.||Chakrabarty, Alok: 3 articles (03/2008 - 03/2007)|
|2.||Chattopadhyay, Nitin: 3 articles (03/2008 - 03/2007)|
|3.||Das, Paramita: 3 articles (03/2008 - 03/2007)|
|4.||Mallick, Arabinda: 3 articles (03/2008 - 03/2007)|
|5.||Erra-Balsells, Rosa: 2 articles (12/2012 - 06/2010)|
|6.||Gonzalez, M Micaela: 2 articles (12/2012 - 06/2010)|
|7.||Cabrerizo, Franco M: 2 articles (12/2012 - 06/2010)|
|8.||Faraji, Ayda: 2 articles (09/2012 - 12/2010)|
|9.||Haghdoost-Yazdi, Hashem: 2 articles (09/2012 - 12/2010)|
|10.||Ostergren, A: 2 articles (07/2007 - 03/2006)|
|1.||Parkinsonian Disorders (Parkinsonism)
09/01/2012 - "This study was designed to further examine the effect of norharman (NH), a BC which in mammalian brain occurs at high levels in the substantia nigra, on the development of Parkinsonism-like behaviors in rats. "
09/01/2012 - "Intracerebral injection of low amounts of norharman induces moderate Parkinsonism-like behavioral symptoms in rat."
12/20/2010 - "Long term exposure to norharman exacerbates 6-hydroxydopamine-induced parkinsonism: possible involvement of L-type Ca2+ channels."
12/20/2010 - "While treatment with nifedipine improved behavioral symptoms of the parkinsonism, treatment with both nifedipine and norharman had no affect on these symptoms. "
12/20/2010 - "This study was designed to assess effect of long term exposure to norharman, a BC compound which in mammalian brain occurs at high levels in the substantia nigra, on the progress of parkinsonism induced by 6-hydroxydopamine (6-OHDA). "
06/01/2006 - "Identification of norharman as the cytotoxic compound produced by the sponge (Hymeniacidon perleve)-associated marine bacterium Pseudoalteromonas piscicida and its apoptotic effect on cancer cells."
01/01/1985 - "Simultaneous treatment with norharman or BP did not affect the tumor response of the larynx. "
06/01/2006 - "Norharman showed cytotoxicity towards both the HeLa cervical-cancer cell line and the BGC-823 stomach-cancer cell line, with an IC(50) of 5 microg/ml. Several methods were used to study the mechanism by which norharman is cytotoxic to HeLa cells. "
03/27/2008 - "Steady-state and time-resolved fluorometric techniques have been exploited to study the photophysical and distribution behavior of an efficient cancer cell photosensitizer, norharmane (NHM), in well-characterized, biomimicking nanocavities formed by cationic micelles with varying surfactant chain length. "
11/01/2014 - "Light-stable bis(norharmane)silver(I) compounds: synthesis, characterization and antiproliferative effects in cancer cells."
|3.||Cocaine-Related Disorders (Cocaine Addiction)
|4.||Substance-Related Disorders (Drug Abuse)
|5.||Stomach Neoplasms (Stomach Cancer)
|2.||GABA-A Receptors (GABA(A) Receptor)
|3.||Glutamic Acid (Glutamate)
|4.||Glutamate Receptors (Glutamate Receptor)
|5.||Oxidopamine (6 Hydroxydopamine)
|6.||Surface-Active Agents (Surfactants)
|7.||Sodium Tetradecyl Sulfate (Sotradecol)
|8.||Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)
|10.||Bovine Serum Albumin